The regulator tells farmers to limit antibiotic use.
The government division is scrutinizing marketing information for three drugs.
The agency extended the review time for Biogen's Alprolix by three months.
Official numbers are pending, but Reuters notes enrollment appears to be just 3% of the government's goal.
General support for the legislation is up, despite Healthcare.gov woes.
Sebelius took the heat for Healthcare.gov, promising that most people would be able to shop for coverage online by November.
The agency made good on a pledge to expand Bad Ad with a web-based CME course and case studies representing common problems.
The American Medical Association (AMA), together with a slew of co-signers, wants CMS to reverse a decision to include textbooks and journal reprints as reportable items.
It was a 15-0 vote for Gilead's sofosbuvir in hep. C. The expedited PDUFA date: Dec. 8. Janssen's simeprivir was endorsed the day before.
The hep. C drug is safe and effective when used in combination with other therapies, according to information posted by FDA reviewers.